Back to search
FDAFDA · Food and drugs·Recall number D-1096-2014

0.9% Sodium Chloride Injection, USP 1000 mL Flexible Container, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7983-09

Published March 12, 2014 · Recall initiated: February 11, 2014

Summary

FDA records drug Class II recall D-1096-2014, published March 12, 2014 and initiated February 11, 2014. Recalling firm: Hospira Inc.; Status: Terminated; Reported quantity: 603,768 bags; Lot: Lot 34-609-FW; Exp 10/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility:Solution leaking through the port cover of the primary container, which was identified during a retain sample visual inspection.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Hospira Inc.
Distributor
Nationwide and Puerto Rico
Lot
Lot 34-609-FW; Exp 10/15
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was 0.9% Sodium Chloride Injection, USP 1000 mL Flexible Container, Rx Only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-7983-09 recalled?

Yes. FDA published recall D-1096-2014 on March 12, 2014. Reported hazard: Lack of Assurance of Sterility:Solution leaking through the port cover of the primary container, which was identified during a retain sample visual inspection.

What should I do if I have this product?

Voluntary: Firm initiated · Letter